Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

August 21, 2023 5:41 (London Time)

Aytu BioPharma

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.7717
MarketCap: 9,334,644.0
High: 1.79 Low: 1.69

Open: 1.78 Close: 1.69 Change: -0.09

Our AI found some flaws in Aytu BioPharma.

How much time have you spent trying to decide whether investing in Aytu BioPharma? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Aytu BioPharma are: …

Concept Map

...

Semantic Network

...

Stock Summary

Aytu Biopharma, Inc. focuses on developing and commercializing novel therapeutics and consumer healthcare products. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in.

Today's Summary

Aytu BioPharma Announces 1-for-20 Reverse Stock Split. Chief Executive Officer Awarded $64K Worth of Stock Options. Chief Business Officer at Aytu Biopharma Acquires Company Stock Options Worth 7,000 Shares.

Today's News

Aytu BioPharma Announces 1-for-20 Reverse Stock Split. Chief Executive Officer Awarded $64K Worth of Stock Options. Chief Business Officer at Aytu Biopharma Acquires Company Stock Options Worth 7,000 Shares.

Stock Profile

"Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado."

Keywords

This document will help you to evaluate Aytu BioPharma without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Aytu BioPharma are: Stock, Aytu, Chief, Officer, Worth, Options, BioPharma, and the most common words in the summary are: state, united, nasdaq, therapeutic, follow, stock, market, . One of the sentences in the summary was: Chief Business Officer at Aytu Biopharma Acquires Company Stock Options Worth 7,000 Shares.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #state #united #nasdaq #therapeutic #follow #stock #market.

Read more →

Related Results

...
February 24, 2024 7:27 (London Time)

Aytu BioPharma

Aytu BioPharma reports record revenue from ADHD asset - prism marketview. Company to Report Second Quarter Fiscal 2024 Financial and Operational Res…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.3612
MarketCap: 16,313,059.0
High: 2.99 Low: 2.82

Open: 2.91 Close: 2.93 Change: 0.02

Read more →
...
July 05, 2023 14:44 (London Time)

Aytu BioPharma

Aytu BioPharma had revenue of $104.12M in the twelve months ending March 31, 2023, with 12.31% growth year-over-year. In the fiscal year ending June…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.6369
MarketCap: 8,837,532.0
High: 1.75 Low: 1.72

Open: 1.73 Close: 1.72 Change: -0.01

Read more →
...
August 21, 2023 5:41 (London Time)

Aytu BioPharma

Aytu BioPharma Announces 1-for-20 Reverse Stock Split. Chief Executive Officer Awarded $64K Worth of Stock Options. Chief Business Officer at Aytu B…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.7717
MarketCap: 9,334,644.0
High: 1.79 Low: 1.69

Open: 1.78 Close: 1.69 Change: -0.09

Read more →
...
April 27, 2023 23:12 (London Time)

Aytu BioPharma

Aytu Biopharmas stock price per share is $2.43 today (as of Apr 26, 2023) Aytu BioPharma stock is down -3.37% while the S&P 500 has gained 1.19%. Ay…
Sector: Pharmaceuticals
Ticker: AYTU
Sentiment: 0.9287
MarketCap: 8,993,354
High: 2.84 Low: 2.25

Open: 2.6 Close: 2.38 Change: -0.22

Read more →